Abciximab

Type: Product
Name: Abciximab
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Methods of treating mixed dyslipidemia

Description of the InventionBACKGROUNDCardiovascular disease is one of the leading causes of death in the United States and most European countries. It is estimated that over 70 million people in the United States alone suffer from a cardiovascular disease ... [Published PharmCast - Apr 08 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Coronary Heart Disease Medications

Medical Editor:What are the different types of coronary heart disease medicines?Many different types of medications are used to treatcoronary heart disease ,also called coronary artery disease, depending on the patient's needs. You maybe prescribed antiplatelet ... [Published RxList - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 2 reports

Reply Intracoronary Versus Intravenous Abciximab Bolus Administration

We thank Dr. De Rosa and colleagues for the interest in our work ( 1 ,22). We agree that the AIDA STEMI (Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction) trial might have been underpowered to detect small differences in clinical event ... [Published Journal of the American College of Cardiology - Apr 01 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Hemorrhagic Risk and Bivalirudin vs UFH in PCI

Bittl JA, Chaitman BR, Feit F, et al. Bivalirudin versus heparin during angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J 2001;142:952–9.Lincoff AM, Bittl JA, Kleiman NS, et al, ... [Published General Medicine eJournal - Mar 24 2014]
First reported Mar 16 2014 - Updated Mar 16 2014 - 1 reports

Methods and compositions for the repair and/or regeneration of damaged myocardium

Methods, compositions, and kits for repairing damaged myocardium and/or myocardial cells including the administration cytokines are disclosed and claimed. Methods and compositions for the development of large arteries and vessels are also disclosed and ... [Published PharmCast - Mar 16 2014]
First reported Mar 02 2014 - Updated Mar 02 2014 - 1 reports

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

The present invention relates to methods and compositions for pretargeting delivery of therapeutic agents. In preferred embodiments, the pretargeting method comprises: a) administering a bispecific antibody with a first binding site for a disease-associated ... [Published PharmCast - Mar 02 2014]

More Content

All (7) | News (7) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Methods of treating mixed dyslipidemia [Published PharmCast - Apr 08 2014]
Coronary Heart Disease Medications [Published RxList - Apr 03 2014]
Reply Intracoronary Versus Intravenous Abcixima... [Published Journal of the American College of Cardiology - Apr 01 2014]
Intracoronary Versus Intravenous Abciximab Bolu... [Published Journal of the American College of Cardiology - Apr 01 2014]
Hemorrhagic Risk and Bivalirudin vs UFH in PCI [Published General Medicine eJournal - Mar 24 2014]
Methods and compositions for the repair and/or ... [Published PharmCast - Mar 16 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.